BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
about
Fine tuning chemotherapy to match BRCA1 statusBRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.Taxol induces caspase-10-dependent apoptosisCustomized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.DNA double strand break repair and its association with inherited predispositions to breast cancerHistone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.Unprecedented inhibition of tubulin polymerization directed by gold nanoparticles inducing cell cycle arrest and apoptosis.Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma raysPredictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposideReversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells.Drug therapy for hereditary cancersPluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation.Mechanisms of resistance to cabazitaxel.Drug resistance and its significance for treatment decisions in non-small-cell lung cancer.Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy.Predictive factors for response to docetaxel in human breast cancers.The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability.Overview of major classes of plant-derived anticancer drugsp53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K-Akt pathways.Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a review.The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancerLow Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia CellsCan the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cellsThe predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.Parameters for individualizing systemic therapy in non-small cell lung cancerAnti-tumor activity of Eurycoma longifolia root extracts against K-562 cell line: in vitro and in vivo study.Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer.Role of genotyping in non-small cell lung cancer treatment: current status.Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Molecular biomarkers for predicting chemotherapy response in lung cancer.Apoptosis and molecular targeting therapy in cancer.BRCA1 regulates the interferon gamma-mediated apoptotic response.Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles.
P2860
Q27694529-EEC45107-325C-478E-8A05-786F3A358476Q27851697-7D527C80-B093-4F20-AD74-D4F56D97030BQ28285037-27BC964E-03D7-45EC-A95B-9F37EABAB9DBQ33438894-C4086637-CF6F-4F4C-8C2F-811C0B7C1565Q33440553-B4570E2E-E1CC-40EC-8239-F5B168434A3AQ33732268-FA689972-CEEC-42C5-8C6F-DDEF8CF09405Q34114810-9BFC2463-761C-4E31-92BC-DACD160C49CEQ34157084-A882B5CA-9CFB-4DF8-ABD1-86F94F347219Q34550974-C1C3CE26-2008-4CAA-899D-698D2F91855AQ34667431-F2B4C013-3778-4FD4-BCC6-474E372620CAQ34770605-B9DC73F4-9032-487C-9D8C-9D0EA9998EA8Q34994818-651CF3ED-97C1-4881-B37A-48632454FC82Q35096634-B958A345-8B76-4B9F-A82B-8F2B62EE070AQ35208929-3B896F88-3305-4E99-949B-44BEE32B64EFQ35284749-F134E471-5381-4938-A81C-3D54AF606BC6Q35661531-77428CF3-3749-4B76-8943-4C64144CA818Q36040613-F3E92826-B7A7-42E4-9865-CE5DEFE7B45BQ36273435-7E13BCEE-B304-493F-88D0-164A0EE70EFAQ36521963-C6AADF22-398B-4B10-B93D-17A23E4B3B2FQ36602569-304F22B4-3CE9-4000-BAD8-889E4021AB0CQ36735506-A1C3CF96-BF33-4B16-9D7A-73B00FBE747EQ37006736-C802CBEA-CC03-4AAE-A600-BE9C5720EF94Q37128739-EBDBEA32-59EE-4432-B4F9-A433327D005AQ37194315-24080A98-DE22-4B17-A7EC-B6AAAC47D026Q37204356-E4A8C468-8AE2-4114-9ABD-FF91473237CCQ37349840-C9AAB0B0-3FF0-4AE7-9AF3-055E78805F77Q37355031-79428CC6-2A3B-4A13-BB97-1B14B7041F7CQ37381571-E218C368-4581-4347-828C-C0CA1F7F4C04Q37398845-B8F051B5-D017-471B-97CF-163BEF8FBB55Q37444876-50944E0A-ABE5-414B-85AF-7FDE3CF5B1D8Q37585309-8FCD86C0-FFEB-491A-A64D-86F07F393E6DQ37677557-D4F1D773-1EB5-419B-8DC0-02E31F193371Q37756959-04B1382B-E4F5-4F34-B6D7-A8DF09C20859Q37956397-72499075-9E11-4E7A-85C9-5683F1332569Q38030053-12645485-7D06-404A-AB0E-BF1A743D4DB6Q38089839-397803F2-0504-43F4-BEF0-D85837C8F933Q38228349-625B6A63-8219-4125-BE76-E2237A3BC341Q38289231-D899CBD7-4A62-4FEF-8056-81A6684EE7BEQ38319987-718F0623-4559-4F1A-8B3E-719322534E12Q38735063-80AF1D3D-1918-4C5E-986B-E820289C093A
P2860
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@en
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@nl
type
label
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@en
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@nl
prefLabel
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@en
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@nl
P2093
P356
P1433
P1476
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
@en
P2093
Gilmore PM
Johnston PG
Maheswaran S
P2888
P304
P356
10.1038/SJ.ONC.1204712
P407
P577
2001-09-01T00:00:00Z
P5875
P6179
1019846392